Literature DB >> 937380

Hospital-associated bacterial meningitis.

G R Hodges, R L Perkins.   

Abstract

Eighteen of 349 cases (5.2 per cent) of bacterial meningitis seen between 1949 and 1973 were hospital-associated (developed after admission to the hospital). The patients were adults, usually males, and developed symptoms and signs of meningitis from 2 to 23 days (mean, 10.1 days) after hospital admission. The diagnosis of bacterial meningitis was made from less than 1 day to 15 days (mean, 4.8 days) after the onset of symptoms. Fourteen of the 18 patients had received antibiotics during the week prior to developing meningitis. Nine (50 per cent) had a chronic, noninfection, underlying illness. Diagnostic or surgical procedures involving the neuraxis or adjacent structures preceded the development of meningitis in 10 of the 18 patients (56 per cent). Only 6 of the 18 patients survived their infection. Prompt recognition, diagnosis, and therapy of hospital-associated meningitis in high-risk patients may reduce the significant mortality.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 937380     DOI: 10.1097/00000441-197605000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Penetration of aztreonam into cerebrospinal fluid and brain of noninfected rabbits and rabbits with experimental meningitis caused by Pseudomonas aeruginosa.

Authors:  L J Strausbaugh; C R Bodem; P R Laun
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

2.  Nosocomial bacterial and fungal meningitis in cancer patients.

Authors:  J Trupl; T Minarik; S Spanik; J Sufliarsky; V Krcmery
Journal:  Support Care Cancer       Date:  1995-11       Impact factor: 3.603

3.  The causes and treatment outcomes of 91 patients with adult nosocomial meningitis.

Authors:  Hye-In Kim; Shin-Woo Kim; Ga-Young Park; Eu-Gene Kwon; Hyo-Hoon Kim; Ju-Young Jeong; Hyun-Ha Chang; Jong-Myung Lee; Neung-Su Kim
Journal:  Korean J Intern Med       Date:  2012-05-31       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.